Effect of dual residual risk of cholesterol and inflammation on all-cause mortality in patients with cardiovascular disease.

Yang, Ling; Yue, Qing; Fang, Fang; Zhang, Yinggen; Liu, Peipei; Zhang, Zihao; Wang, Guodong; Chen, Shuohua; Wu, Shouling; Yang, Xiuhong

Yang, Ling; Yue, Qing; Fang, Fang; Zhang, Yinggen; Liu, Peipei; Zhang, Zihao; Wang, Guodong; Chen, Shuohua; Wu, Shouling; Yang, Xiuhong.

Afiliación

Yang L; School of Public Health, North China University of Science and Technology, No. 21 Bohai Road, Caofeidian Eco-city, Tangshan, 063210, Hebei, China.
Yue Q; School of Public Health, North China University of Science and Technology, No. 21 Bohai Road, Caofeidian Eco-city, Tangshan, 063210, Hebei, China.
Fang F; Hebei Key Laboratory for Chronic Diseases, Tangshan Key Laboratory for Preclinical and Basic Research On Chronic Diseases, School of Basic Medical Sciences, North China University of Science and Technology, No. 21 Bohai Road, Caofeidian Eco-city, Tangshan, 063210, Hebei, China.
Zhang Y; Department of Nuclear Medicine, Kailuan General Hospital, 57 Xinhua East Rd, Tangshan, 063000, Hebei, China.
Liu P; School of Public Health, North China University of Science and Technology, No. 21 Bohai Road, Caofeidian Eco-city, Tangshan, 063210, Hebei, China.
Zhang Z; School of Public Health, North China University of Science and Technology, No. 21 Bohai Road, Caofeidian Eco-city, Tangshan, 063210, Hebei, China.
Wang G; Department of Cardiology, Kailuan General Hospital, 57 Xinhua East Rd, Tangshan, 063000, Hebei, China.
Chen S; Department of Cardiology, Kailuan General Hospital, 57 Xinhua East Rd, Tangshan, 063000, Hebei, China.
Wu S; Department of Cardiology, Kailuan General Hospital, 57 Xinhua East Rd, Tangshan, 063000, Hebei, China. drwusl@163.com.
Yang X; School of Public Health, North China University of Science and Technology, No. 21 Bohai Road, Caofeidian Eco-city, Tangshan, 063210, Hebei, China. yangxiuhong@ncst.edu.cn.

Cardiovasc Diabetol ; 22(1): 96, 2023 04 24.

Article en En | MEDLINE | ID: mdl-37095492

Asunto(s)

Enfermedades Cardiovasculares; Inhibidores de Hidroximetilglutaril-CoA Reductasas; Masculino; Humanos; Persona de Mediana Edad; Anciano; Femenino; Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico; LDL-Colesterol; Glucemia; Colesterol; Factores de Riesgo; Inflamación/tratamiento farmacológico

Palabras clave

All-cause mortality; Hypersensitive C-reactive protein; Low-density lipoprotein cholesterol; Residual risk

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Inhibidores de Hidroximetilglutaril-CoA Reductasas Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cardiovasc Diabetol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google